Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Hoffmann

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2012
Initial analysis of the international association for the study of lung cancer mesothelioma databaseValerie W Rusch, Dorothy Giroux, Catherine Kennedy, et al.
Oncoimmunology|November 20, 2019
Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancerSeyer Safi, Yoshikane Yamauchi, Slava Stamova, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2017
Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapyJuliane Hörner-Rieber, Denise Bernhardt, Julian Dern, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committeeHarvey I Pass, Dorothy Giroux, Catherine Kennedy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2016
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International ParticipationHarvey Pass, Dorothy Giroux, Catherine Kennedy, et al.
RNA Biology|December 1, 2018
Targeting LINC00673 expression triggers cellular senescence in lung cancerAnna Roth, Karine Boulay, Matthias Groß, et al.
Cancers|October 16, 2024
Germline Polymorphisms Associated with Overall Survival in Lung Adenocarcinoma: Genome-Wide AnalysisFrancesca Minnai, Sara Noci, Martina Esposito, et al.
The European Respiratory Journal|August 31, 2013
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotypeArne Warth, Roland Penzel, Heike Lindenmaier, et al.
Endocrine Pathology|November 6, 2025
Phenotypic Landscape of Pulmonary Neuroendocrine Tumors: Subtyped by OTP/ASCL1 Expression Correlated with Histology, Hormones and OutcomeAyako Ura, Katja Evert, Matthias Evert, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2008
Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patientsNiels Reinmuth, Anna Jauch, Elizabeth Chang Xu, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2012
Initial analysis of the international association for the study of lung cancer mesothelioma databaseValerie W Rusch, Dorothy Giroux, Catherine Kennedy, et al.
Oncoimmunology|November 20, 2019
Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancerSeyer Safi, Yoshikane Yamauchi, Slava Stamova, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2017
Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapyJuliane Hörner-Rieber, Denise Bernhardt, Julian Dern, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committeeHarvey I Pass, Dorothy Giroux, Catherine Kennedy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2016
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International ParticipationHarvey Pass, Dorothy Giroux, Catherine Kennedy, et al.
RNA Biology|December 1, 2018
Targeting LINC00673 expression triggers cellular senescence in lung cancerAnna Roth, Karine Boulay, Matthias Groß, et al.
Cancers|October 16, 2024
Germline Polymorphisms Associated with Overall Survival in Lung Adenocarcinoma: Genome-Wide AnalysisFrancesca Minnai, Sara Noci, Martina Esposito, et al.
The European Respiratory Journal|August 31, 2013
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotypeArne Warth, Roland Penzel, Heike Lindenmaier, et al.
Endocrine Pathology|November 6, 2025
Phenotypic Landscape of Pulmonary Neuroendocrine Tumors: Subtyped by OTP/ASCL1 Expression Correlated with Histology, Hormones and OutcomeAyako Ura, Katja Evert, Matthias Evert, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2008
Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patientsNiels Reinmuth, Anna Jauch, Elizabeth Chang Xu, et al.
Pageof 15